TipRanks
Go Ultimate55% OFF

Aktis Oncology, Inc. (AKTS) Income Statement

Aktis Oncology, Inc. Income Statement

Last quarter (Q2 2026), Aktis Oncology, Inc.'s total revenue was $3.38M, an increase of 262.70% from the same quarter last year. In Q2, Aktis Oncology, Inc.'s net income was $-24.14M. See Aktis Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22
$ 6.50M$ 1.49M$ 0.00$ 0.00
$ 6.50M$ 1.49M$ 0.00$ 0.00
$ 81.18M$ 53.54M$ 34.79M$ 19.76M
Depreciation and Amortization$ 2.33M$ 1.57M$ 1.12M$ 445.00K
$ -61.40M$ -42.41M$ -27.52M$ -17.48M
$ -74.68M$ -52.05M$ -34.79M$ -19.76M
$ 10.95M$ 8.07M$ 6.15M$ 1.83M
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
$ -63.73M$ -43.98M$ -28.64M$ -17.93M
Per Share Metrics
Basic EPS$ -1.19$ -1.26$ -0.82$ -0.51
Diluted EPS$ -1.19$ -1.26$ -0.82$ -0.51
Weighted Average Shares Outstanding52.52M34.86M34.86M34.86M
Weighted Average Shares Outstanding (Diluted)52.52M34.86M34.86M34.86M

Currency in USD

Aktis Oncology, Inc. Earnings and Revenue History

-80M-40M040M-3200 %-2400 %-1600 %-800 %EarningsProfit Margin2022202320242025RevenueEarningsProfit Margin